Integer Holdings Corp (ITGR) stock
ITGRNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Oct 2, 2026Last filing: 10-Q on Oct 29, 2026Score 8/3022% above fair value
$126.42−0.26 (-0.21%)
Close on Nov 12, 2026Market cap $4.30BP/E 42.4Yield –
Integer EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Integer's EPS for the twelve months ending Oct 2, 2026 was $2.98, up 24.7% year over year. For fiscal 2025 it was $2.89, down 14.0% from the year before. The highest annual figure on record is $5.15 in fiscal 2018.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.89 | -14.0% |
| FY2024 | Dec 31, 2024 | $3.36 | +24.9% |
| FY2023 | Dec 31, 2023 | $2.69 | +35.2% |
| FY2022 | Dec 31, 2022 | $1.99 | -31.6% |
| FY2021 | Dec 31, 2021 | $2.91 | +24.9% |
| FY2020 | Dec 31, 2020 | $2.33 | -20.2% |
| FY2019 | Dec 31, 2019 | $2.92 | -43.3% |
| FY2018 | Dec 28, 2018 | $5.15 | +147.6% |
| FY2017 | Dec 29, 2017 | $2.08 | +994.7% |
| FY2016 | Dec 30, 2016 | $0.19 | – |
| FY2015 | Jan 1, 2016 | -$0.29 | -113.6% |
| FY2014 | Jan 2, 2015 | $2.14 | +49.7% |
| FY2013 | Jan 3, 2014 | $1.43 | – |
| FY2012 | Dec 28, 2012 | -$0.20 | -114.3% |
| FY2011 | Dec 30, 2011 | $1.40 | 0.0% |
| FY2010 | Dec 31, 2010 | $1.40 | – |
| FY2009 | Jan 1, 2010 | -$0.39 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Oct 2, 2026 | $0.43 | -61.3% |
| Q2 FY2026 | Jul 3, 2026 | $0.69 | -33.7% |
| Q1 FY2026 | Apr 3, 2026 | $0.48 | – |
| Q4 FY2025 | Dec 31, 2025 | $1.38 | +53.3% |
| Q3 FY2025 | Sep 26, 2025 | $1.11 | +12.1% |
| Q2 FY2025 | Jun 27, 2025 | $1.04 | +18.2% |
| Q1 FY2025 | Mar 28, 2025 | -$0.66 | -211.9% |
| Q4 FY2024 | Dec 31, 2024 | $0.90 | +15.4% |
| Q3 FY2024 | Sep 27, 2024 | $0.99 | +22.2% |
| Q2 FY2024 | Jun 28, 2024 | $0.88 | +23.9% |
| Q1 FY2024 | Mar 29, 2024 | $0.59 | +51.3% |
| Q4 FY2023 | Dec 31, 2023 | $0.78 | +44.4% |
| Q3 FY2023 | Sep 29, 2023 | $0.81 | +68.8% |
| Q2 FY2023 | Jun 30, 2023 | $0.71 | +14.5% |
| Q1 FY2023 | Mar 31, 2023 | $0.39 | +14.7% |
| Q4 FY2022 | Dec 31, 2022 | $0.54 | -23.9% |
| Q3 FY2022 | Sep 30, 2022 | $0.48 | -27.3% |
| Q2 FY2022 | Jul 1, 2022 | $0.62 | -30.3% |
| Q1 FY2022 | Apr 1, 2022 | $0.34 | -47.7% |
| Q4 FY2021 | Dec 31, 2021 | $0.71 | +51.1% |
| Q3 FY2021 | Oct 1, 2021 | $0.66 | -28.3% |
| Q2 FY2021 | Jul 2, 2021 | $0.89 | +8800.0% |
| Q1 FY2021 | Apr 2, 2021 | $0.65 | -30.9% |
| Q4 FY2020 | Dec 31, 2020 | $0.47 | +42.4% |
| Q3 FY2020 | Oct 2, 2020 | $0.92 | 0.0% |
| Q2 FY2020 | Jul 3, 2020 | $0.01 | -98.8% |
| Q1 FY2020 | Apr 3, 2020 | $0.94 | +44.6% |
| Q4 FY2019 | Dec 31, 2019 | $0.33 | -43.1% |
| Q3 FY2019 | Sep 27, 2019 | $0.92 | – |
| Q2 FY2019 | Jun 28, 2019 | $0.85 | +21.4% |
| Q1 FY2019 | Mar 29, 2019 | $0.65 | +62.5% |
| Q4 FY2018 | Dec 28, 2018 | $0.58 | -65.7% |
| Q3 FY2018 | Sep 28, 2018 | -$0.26 | -141.9% |
| Q2 FY2018 | Jun 29, 2018 | $0.70 | +133.3% |
| Q1 FY2018 | Mar 30, 2018 | $0.40 | +344.4% |
| Q4 FY2017 | Dec 29, 2017 | $1.69 | +576.0% |
| Q3 FY2017 | Sep 29, 2017 | $0.62 | – |
| Q2 FY2017 | Jun 30, 2017 | $0.30 | – |
| Q1 FY2017 | Mar 31, 2017 | $0.09 | – |
| Q4 FY2016 | Dec 30, 2016 | $0.25 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?